Biotech marijuana: Israeli startups aim to breed cannabis plant that’s easier to cultivate

marijuana image
Image: Saint Peters

Israeli medical cannabis company Cann10 has signed an agreement to team up with Israeli biotech company Epigenetics to form Cann10 EpiGen, a joint company focused on using cutting-edge epigenetics technology to make a version of the cannabis plant that is easier to cultivate and farm.

Cann10 and Epigenetics will jointly invest dozens of thousands of dollars to promote research of the cannabis plant using the new technology, with the purpose of improving the plant’s desirable traits and increasing the efficiency and quality of its growth .

Epigenetics is a state-of-the-art third-generation breeding technology, that focuses on revealing hidden parts of the DNA of the plant and enabling select genes to manifest themselves.

ADVERTISEMENT

This method is currently applied globally to various agricultural crops. For example, in experiments performed on tomatoes and corn, this technology managed to multiply the plants’ photosynthesis level by 100, and in this manner increase the yield significantly.

Related article:  Billion-year-old microbes could give us new food, fuel sources—if we can figure out how to use them

Read full, original article: Israeli start-ups to make epi genetic mega-cannabis together

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend